AntineoplasticsEGFR and KRAS mutations with acquired resistance to crizotinib: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2014年 / 1515卷 / 1期
关键词：
D O I：
10.1007/s40278-014-2726-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：31 / 31
相关论文
共 50 条
  • [41] InfliximabDevelopment of acquired resistance: case report
    Reactions Weekly, 2023, 1939 (1) : 250 - 250
  • [42] GefitinibDevelopment of acquired resistance: case report
    Reactions Weekly, 2018, 1703 (1) : 120 - 120
  • [43] Crizotinib/erlotinib/osimertinibDrug resistance, acne and anorexia: case report
    Reactions Weekly, 2021, 1852 (1) : 144 - 144
  • [44] Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
    Misale, Sandra
    Yaeger, Rona
    Hobor, Sebastijan
    Scala, Elisa
    Janakiraman, Manickam
    Liska, David
    Valtorta, Emanuele
    Schiavo, Roberta
    Buscarino, Michela
    Siravegna, Giulia
    Bencardino, Katia
    Cercek, Andrea
    Chen, Chin-Tung
    Veronese, Silvio
    Zanon, Carlo
    Sartore-Bianchi, Andrea
    Gambacorta, Marcello
    Gallicchio, Margherita
    Vakiani, Efsevia
    Boscaro, Valentina
    Medico, Enzo
    Weiser, Martin
    Siena, Salvatore
    Di Nicolantonio, Federica
    Solit, David
    Bardelli, Alberto
    NATURE, 2012, 486 (7404) : 532 - U131
  • [45] Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
    Sandra Misale
    Rona Yaeger
    Sebastijan Hobor
    Elisa Scala
    Manickam Janakiraman
    David Liska
    Emanuele Valtorta
    Roberta Schiavo
    Michela Buscarino
    Giulia Siravegna
    Katia Bencardino
    Andrea Cercek
    Chin-Tung Chen
    Silvio Veronese
    Carlo Zanon
    Andrea Sartore-Bianchi
    Marcello Gambacorta
    Margherita Gallicchio
    Efsevia Vakiani
    Valentina Boscaro
    Enzo Medico
    Martin Weiser
    Salvatore Siena
    Federica Di Nicolantonio
    David Solit
    Alberto Bardelli
    Nature, 2012, 486 : 532 - 536
  • [46] First Case Report of a Uterine Angiolipoleiomyoma With KRAS and KIT Mutations
    Verocq, Camille
    Noel, Jean-Christophe
    Ouertani, Salah
    D'Haene, Nicky
    Catteau, Xavier
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2022, 41 (06) : 578 - 582
  • [47] The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations
    Jori, Balazs
    Voessing, Christine
    Pirngruber, Judith
    Willing, Eva Maria
    Arndt, Kathrin
    Falk, Markus
    Tiemann, Markus
    Heukamp, Lukas C.
    Hoffknecht, Petra
    CURRENT ONCOLOGY, 2023, 30 (10) : 8805 - 8814
  • [48] Crizotinib/erlotinib interactionDrug resistance and various other toxicities: case report
    Reactions Weekly, 2015, 1567 (1) : 74 - 74
  • [49] Crizotinib/osimertinibVarious toxicity followed by drug-resistance: case report
    Reactions Weekly, 2021, 1860 (1) : 134 - 134
  • [50] CrizotinibDevelopment of resistance to crizotinib during treatment of lung cancer: case report
    Reactions Weekly, 2018, 1728 (1) : 114 - 114
12345